Across TCGA pan-cancer cohorts, P4HA3 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated P4HA3 data layer compared with 6 for mutation status and 3 for mass-spec protein.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher P4HA3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated P4HA3 expression acts as an unfavorable survival marker, although some lineages such as DLBC and LIHC show a favorable association.
KIRP, BLCA, and CESC are the cancer types where P4HA3 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.